Back

Bone marrow haematopoietic stem cells influence liver homeostatic networks and cancer development after dietary intervention

Alipour Talash, G.; Langfelder, P.; Vitale, D.; Karimi Azardaryany, M.; Belgard, T. G.; Choo, J.; Rogers, G.; Ho, V.; Ramezani-Moghadam, M.; Dervish, S.; Lai, J.; Gloss, B. S.; McLeod, D.; Eslam, M.; Liddle, C.; Qiao, L.; George, J.; Esmaili, S.

2022-04-16 systems biology
10.1101/2022.04.16.488543 bioRxiv
Show abstract

A holistic understanding of anti-tumor immunity requires examination of systemic immunity beyond the tumor microenvironment. This link between systemic and tumor immune activity is underexplored. We demonstrate that a stronger Type I interferon response in human liver tumors predicts better survival and correlates with the immune response in the adjacent non-tumor liver. Further, in patients with liver cancer, clonal hematopoiesis (CH) (a marker of systemic immune activation) is associated with a trend towards improved survival. In a mouse model of liver cancer, basal liver immune responses correlate with the degree of bone marrow hematopoietic stem and progenitor cell responses. A higher systemic and liver immune response, marked by innate myeloid cell infiltration reduces tumor burden, while sub-optimal systemic and liver immunity corresponded with a higher tumor burden. Our findings indicate that the state of bone marrow hematopoiesis impacts liver tumor outcomes, offering both therapeutic and prognostic opportunities.

Matching journals

The top 4 journals account for 50% of the predicted probability mass.

50% of probability mass above

"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.